Childrens Mercy - Kansas City

Researchers at Children’s Mercy have developed Astrolabe, software for predicting a patient’s response to medications using whole genome sequencing. When used with a newly developed, low cost sequencing method, the software can identify the pharmacogenetics profile of each patient, enabling physicians to tailor medication selection to the patient’s DNA. Join Neil Miller, Director of Informatics and Software Development in the Children’s Mercy Genome Center, as he introduces us to the Astrolabe software and the benefits it will offer to physicians and our pediatric patients.